GenFleet Therapeutics (Shanghai) Inc
HKEX:2595

Watchlist Manager
GenFleet Therapeutics (Shanghai) Inc Logo
GenFleet Therapeutics (Shanghai) Inc
HKEX:2595
Watchlist
Price: 31.36 HKD 0.51%
Market Cap: 11.6B HKD

Intrinsic Value

The intrinsic value of one GenFleet Therapeutics (Shanghai) Inc stock under the Base Case scenario is 3.29 HKD. Compared to the current market price of 31.36 HKD, GenFleet Therapeutics (Shanghai) Inc is Overvalued by 90%.

The Intrinsic Value is calculated as the average of DCF and Relative values:

Intrinsic Value
3.29 HKD
Overvaluation 90%
Intrinsic Value
Price
Worst Case
Base Case
Best Case

Valuation History
GenFleet Therapeutics (Shanghai) Inc

What is Valuation History?
Ask AI Assistant
What other research platforms think about GenFleet Therapeutics (Shanghai) Inc?

Let our AI compare Alpha Spread’s intrinsic value with external valuations from Simply Wall St, GuruFocus, ValueInvesting.io, Seeking Alpha, and others.

Discover External Valuations
Why is GenFleet Therapeutics (Shanghai) Inc valued this way?

Let our AI break down the key assumptions behind the intrinsic value calculation for GenFleet Therapeutics (Shanghai) Inc.

Explain Valuation
Compare GenFleet Therapeutics (Shanghai) Inc to

Fundamental Analysis

GenFleet Therapeutics (Shanghai) Inc
Company Overview
Loading...
Economic Moat
Loading...
Contacts
Loading...
How do you feel about GenFleet Therapeutics (Shanghai) Inc?
Bearish
Neutral
Bullish
Financials
Annual
Quarterly
TTM
Annual
Quarterly
TTM

Revenue & Expenses Breakdown
GenFleet Therapeutics (Shanghai) Inc

Balance Sheet Decomposition
GenFleet Therapeutics (Shanghai) Inc

Balance Sheet Decomposition is not available for
GenFleet Therapeutics (Shanghai) Inc
Efficiency

Free Cash Flow Analysis
GenFleet Therapeutics (Shanghai) Inc

Last Value
3-Years Average
FCF Margin
Conversion Rate

Earnings Waterfall
GenFleet Therapeutics (Shanghai) Inc

Revenue
104.7m CNY
Cost of Revenue
-20.1m CNY
Gross Profit
84.6m CNY
Operating Expenses
-383.3m CNY
Operating Income
-298.7m CNY
Other Expenses
-378.9m CNY
Net Income
-677.6m CNY
Fundamental Scores

Profitability Score
Profitability Due Diligence

GenFleet Therapeutics (Shanghai) Inc's profitability score is 45/100. The higher the profitability score, the more profitable the company is.

Exceptional Gross Margin
Strong 3Y Average Gross Margin
Negative 3Y Average Net Margin
Negative 3Y Average Operating Margin
45/100
Profitability
Score

GenFleet Therapeutics (Shanghai) Inc's profitability score is 45/100. The higher the profitability score, the more profitable the company is.

Solvency Score
Solvency Due Diligence

GenFleet Therapeutics (Shanghai) Inc's solvency score is 33/100. The higher the solvency score, the more solvent the company is.

Negative Net Debt
Long-Term Solvency
Short-Term Solvency
Low Interest Coverage
33/100
Solvency
Score

GenFleet Therapeutics (Shanghai) Inc's solvency score is 33/100. The higher the solvency score, the more solvent the company is.

Wall St
Price Targets

Price Targets Summary
GenFleet Therapeutics (Shanghai) Inc

There are no price targets for GenFleet Therapeutics (Shanghai) Inc.
Lowest
Price Target
Not Available
Average
Price Target
Not Available
Highest
Price Target
Not Available
View Analyst Estimates
View Analyst Estimates

Dividends

GenFleet Therapeutics (Shanghai) Inc
does not pay dividends
Shareholder Yield

Current shareholder yield for GenFleet Therapeutics (Shanghai) Inc is .

Shareholder yield represents the total return a company provides to its shareholders, calculated as the sum of dividend yield, buyback yield, and debt paydown yield. What is shareholder yield?

Shareholder Yield
Dividend Yield
No dividends
Buyback Yield
Lowest
Average
Highest
Debt Paydown Yield
Lowest
Average
Highest

Competitive Landscape

Company Market Cap Intrinsic Valuation Profitability Solvency Price Change
1Y 3Y 5Y
What is the Intrinsic Value of one GenFleet Therapeutics (Shanghai) Inc stock?

The intrinsic value of one GenFleet Therapeutics (Shanghai) Inc stock under the Base Case scenario is 3.29 HKD.

Is GenFleet Therapeutics (Shanghai) Inc stock undervalued or overvalued?

Compared to the current market price of 31.36 HKD, GenFleet Therapeutics (Shanghai) Inc is Overvalued by 90%.

Back to Top